Back to APS Research Labs
APS Program Update:
February 2024
Read the new APS Program Update that includes articles on our latest research work, recent award recipients, Dr. Jason Knight and Dr. Ray Zuo, an announcement and thank you to Dr. Trudy Gregory and her family for their generous donation, an update on the DARE-APS study, and the latest edition of the APS Program Community Q&A Series by Dr. Ray Zuo.
Health Lab
Researchers at the University of Michigan Health have unveiled a new mechanism that drives thrombocytopenia and a potential clinically actionable biomarker for antiphospholipid syndrome associated thrombocytopenia.
Research News
Congratulations to Dr. Ray Zuo who received the James A. Shayman, MD Department of Internal Medicine Early Career Endowment Award, one of just three Early Career Endowment Awards presented annually to support research excellence and to attract, recruit, and retain the very brightest of faculty.
Research News
A new first-of-its-kind study, led by Dr. Ramadan Ali, found taxifolin supplements have protective effects on thrombo-inflammatory diseases, such as lupus and APS.
Research News
Eleven faculty members from the Department of Internal Medicine have been named Highly Cited Researchers by Clarivate for 2023. Highly Cited Researchers are selected based on the demonstration of significant and broad influence in their field(s) of research. Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.
Health Lab
University of Michigan researchers found that the overproduction of neutrophil extracellular traps is an important contributing factor to vascular dysfunction in diabetes.
Research News
A new first-of-its-kind study found taxifolin supplements have protective effects on thrombo-inflammatory diseases, such as lupus and antiphospholipid syndrome(APS). Taxifolin, which is also known as dihydroquercetin, is a bioactive plant-derived flavonoid that has a wide range of health-supporting, anti-inflammatory and anti-oxidative properties.